ARCHIVES

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Intramural Funding To Decrease, R01s Increase, Klausner Says

September 15, 1995

In Brief: Senate Tracks Reauthorization n New Institute Bill, Waxman May Go Along: Abe Goldin Dies

August 19, 1988

Mihich Recommendation for Antigen Development In BRMP Summarized

December 14, 1979

ImClone Protocol Generates More Questions Than Answers.

February 15, 2002

NCI Moratorium On New OIG Applications; P01 Funding Steadily Drops

May 1, 1992

High Dose Radiotherapy Plus Chemo Encouraging For Small Cell Lung Cancer

November 27, 2009